Phase I/II Trial of Azacytidine + R-CHOP in Diffuse Large B-Cell Lymphoma.

Trial Profile

Phase I/II Trial of Azacytidine + R-CHOP in Diffuse Large B-Cell Lymphoma.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Azacitidine (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
  • Indications Diffuse large B cell lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 09 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top